Antiseizure drugs Flashcards

1
Q

Phenytoin, fosphenytoin

A
  • Cyclic ureide
  • MOA
  • block high-frequency firing of neurons through action on VG Na+ channels
  • decrease synaptic release of glutamate
  • Kinetics
  • zero-order
  • highly bound to plasma proteins
  • no active metabolites
  • dose-dependent elimination, t1/2 12-36h
  • fosphenytoin is for IV, IM routes
  • Clinical
  • generalized tonic-clonic seizures, partial seizures
  • Tox, int.
  • tox: diplopia, ataxia, gingival hyperplasia, hirsutism, neuropathy
  • int: any drug that binds to plasma proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Phenobarbital (cyclic ureide)

A
  • MOA
  • enhances phasic GABAA receptor responses, reduces excitatory synaptic responses
  • Kinetics
  • nearly complete absorption, not significantly bound to plasma proteins
  • peak conc in 0.5-4h, no active metabolites, t1/2 varies from 75-125h
  • Clinical
  • generalized tonic-clonic seizures, partial seizures, myoclonic seizures, generalized seizures, neonatal seizures, status epilepticus
  • Tox, int.
  • tox: sedation, cognitive issues, ataxia, hyperactivity
  • int: so many drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ethosuximide

A
  • Cyclic ureide
  • MOA
  • reduces low-threshold Ca2+ currents (T-type)
  • Kinetics
  • well absorbed orally, peak levels in 3-7h, not protein-bound, completely metabolized to inactive compounds, t1/2 typically 40h
  • Clinical
  • absence seizures
  • Tox, int.
  • tox: nausea, headache, dizziness, lethargy
  • int: valproate, phenobarbital, phenytoin, carbamazepine, rifampacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Carbamazepine

A
  • Tricyclic
  • MOA
  • blocks high-frequency firing of neurons through action on VG Na+ channels
  • decreases synaptic release of glutamate
  • Kinetics
  • well absorbed orally, peak levels in 6-8h, no significant protein binding, metabolized in part to active 10-11-epoxide
  • t1/2 8-36h
  • Clinical
  • generalized tonic-clonic seizures, partial seizures
  • Tox, int.
  • tox: nausea, diplopia, atazia, hyponatremia, headache
  • int: many
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diazepam

A
  • MOA
  • potentiates GABAA responses
  • Kinetics
  • well absorbed orally, rectal administration gives peak conc in approx 1h with 90% bioavailability
  • IV for status epilepticus
  • highly protein bound, extensively metabolized to several active metabolites, t1/2 2d
  • Clinical
  • status epilepticus, seizure clusters
  • Tox, int.
  • tox: sedation
  • int: additive with sedative-hypnotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clonazepam

A
  • MOA
  • potentiates GABAA responses
  • Kinetics
  • >80% bioavailability, extensively metabolized but no active metabolites, t1/2 20-50h
  • Clinical
  • absence seizures, myoclonic seizures, infantile spasms
  • Tox, int.
  • tox: sedation
  • int: additive with sedative-hypnotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Vigabatrin

A
  • GABA derivate
  • MOA
  • irreversibly inhibits GABA-transaminase
  • Kinetics
  • 70% bioavailable, not bound to plasma proteins, not metabolized
  • Clinical
  • partial seizures, infantile spasms
  • Tox, int.
  • tox: drowsiness, dizziness, psychosis, visual field loss
  • int: minimal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Valproate

A
  • MOA
  • blocks high-frequency firing of neurons, modifies amino acid metabolism
  • Kinetics
  • well absorbed from several formulations, highly bound to plasma proteins, extensively metabolized, t1/2 9-16h
  • Clinical
  • generalized tonic-clonic seizures, partial seizures, generalized seizures, absence seizures, myoclonic seizures
  • Tox, int.
  • tox: nausea tremor, weight gain, hair loss, teratogenic, hepatotoxic
  • int: many
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lamotrigine

A
  • MOA
  • prolongs inactivation of VG Na+ channels
  • acts presynaptically on VG Ca2+ channels, decreasing glutamate release
  • Kinetics
  • well absorbed orally, no significant protein binding, extensively metabolized but no active metabolites, t1/2 25-35h
  • Clinical
  • generalized tonic-clonic seizures, generalized seizures, partial seizures, absence seizures
  • Tox, int.
  • tox: dizziness, headache, diplopia, rash
  • int: many
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Levetiracetam

A
  • MOA
  • action on synaptic protein SV2A
  • Kinetics
  • well absorbed orally, not bound to plasma proteins, metabolized to 3 inactive metabolites, t1/2 6-11h
  • Clinical
  • generalized tonic-clonic seizures, partial seizures, generalized seizures
  • Tox, int.
  • tox: nervousness, dizziness, depression, seizures
  • int: rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly